Association of office blood pressure with ischemic and bleeding events in patients undergoing percutaneous coronary intervention

被引:0
|
作者
Kim, Byung Sik [1 ]
Shin, Jeong-Hun [1 ]
Kim, Woohyeun [2 ]
Kook, Hyungdon [2 ]
Lee, Yonggu [1 ]
Park, Jin-Kyu [2 ]
Shin, Jinho [2 ]
Lim, Young-Hyo [2 ]
机构
[1] Hanyang Univ, Hanyang Univ Guri Hosp, Dept Internal Med, Div Cardiol,Coll Med, Guri, South Korea
[2] Hanyang Univ, Hanyang Univ Seoul Hosp, Dept Internal Med, Div Cardiol,Coll Med, 222 Wangsimni Ro, Seoul 04763, South Korea
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
Blood pressure; Coronary artery disease; Hypertension; Percutaneous coronary intervention; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; HYPERTENSIVE PATIENTS; RISK; OUTCOMES; DISEASE; REVASCULARIZATION; DEFINITIONS; TRIALS;
D O I
10.1038/s41598-024-71060-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Optimal blood pressure (BP) for patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) remains unclear. This study aims to identify the optimal BP by investigating the association between average office BP and future clinical events in patients undergoing PCI. Consecutive patients undergoing PCI from 2012 to 2016 were included. They were divided into five groups according to the average follow-up BP after discharge. The co-primary outcomes were net adverse clinical events (NACE) and major adverse cardiac and cerebrovascular events (MACCE) up to 5 years. NACE was defined as a composite of MACCE (all-cause death, non-fatal myocardial infarction (MI), non-fatal stroke, or any revascularization) or major bleeding. A total of 2845 patients were included, and among them, 787 (27.7%) experienced the NACE during the follow-up period. Patients in the highest SBP group (adjusted hazard ratio [HR] 1.495, confidence interval [CI] 1.189-1.880) and lowest SBP group (adjusted HR 1.625, CI 1.214-2.176) had a significantly higher risk of 5-year NACE. Similar associations were observed between SBP and the risk of MACCE, and similar results based on DBP categories were also observed. There was a J-curve relationship between SBP and DBP with respect to 5-year NACE and MACCE. The nadir point of risk for NACE and MACCE was found at 121.4/74.8 and 120.4/73.7 mmHg. In patients underwent PCI, there is a significant correlation between office BP level and clinical events, indicates the importance of efforts for optimal BP control to reduce ischemic and bleeding events.Trial registration: HanYang University Medical Center (HYUMC) Registry, NCT05935397.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Prognostic Value of Machine-Learning-Based PRAISE Score for Ischemic and Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Shi, Boqun
    Wang, Hao-Yu
    Liu, Jinpeng
    Cai, Zhongxing
    Song, Chenxi
    Yin, Dong
    Wang, Hongjian
    Dong, Qiuting
    Song, Weihua
    Dou, Ke-Fei
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (07):
  • [32] Association of Lipoprotein(a) With Recurrent Ischemic Events Following Percutaneous Coronary Intervention
    Yoon, Yong-Hoon
    Ahn, Jung-Min
    Kang, Do-Yoon
    Lee, Pil Hyung
    Kang, Soo-Jin
    Park, Duk-Woo
    Lee, Seung-Whan
    Kim, Young-Hak
    Han, Ki Hoon
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (18) : 2059 - 2068
  • [33] Obstructive sleep apnea affects the clinical outcomes of patients undergoing percutaneous coronary intervention
    Zhang, Jun-jie
    Gao, Xiao-fei
    Ge, Zhen
    Jiang, Xiao-Min
    Xiao, Ping-xi
    Tian, Nai-liang
    Kan, Jing
    Lee, Chi-Hang
    Chen, Shao-Liang
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 871 - 878
  • [34] Association Between Coronary Arterial Dominance and Mortality in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Chiaco, John Michael S. Chua
    Wolf, Robert
    Normand, Sharon-Lise
    Rosenthal, Eric
    Mittleman, Murray
    Carrozzas, Joseph
    Lovett, Ann
    Ho, Kalon
    Parikh, Nisha
    CIRCULATION, 2012, 126 (21)
  • [35] Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention
    Hiew, C.
    Duggan, A.
    de Malmanche, T.
    Hatton, R.
    Baker, F.
    Attia, J.
    Collins, N.
    INTERNAL MEDICINE JOURNAL, 2012, 42 (03) : 289 - 293
  • [36] Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention
    Ricottini, Elisabetta
    Gatto, Laura
    Nusca, Annunziata
    Melfi, Rosetta
    Mangiacapra, Fabio
    Albano, Marzia
    Cavallaro, Camilla
    Pozzilli, Paolo
    Di Sciascio, Germano
    Prati, Francesco
    Ussia, Gian Paolo
    Grigioni, Francesco
    CLINICAL NUTRITION ESPEN, 2023, 58 : 104 - 110
  • [37] Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients A real world retrospective study
    Hu, Yue-cheng
    Yao, Wei-jie
    Jin, Dong-xia
    Zhang, Jing-xia
    Wang, Le
    Zhang, Rui
    Xu, Jing-han
    Cong, Hong-liang
    MEDICINE, 2021, 100 (10) : E25003
  • [38] Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention
    Kourtis, Konstantinos
    Bourazana, Angeliki
    Xanthopoulos, Andrew
    Skoularigkis, Spyridon
    Papadakis, Emmanouil
    Patsilinakos, Sotirios
    Skoularigis, John
    MEDICINA-LITHUANIA, 2024, 60 (01):
  • [39] Sleep profile and the risk of cardiovascular events in patients undergoing percutaneous coronary intervention
    Zhu, Chenya
    Lu, Yang
    Cheng, Ming
    Zhou, Zichun
    Zhang, Yuxian
    Lei, Xiaoqing
    Wang, Xiaohua
    Hou, Yunying
    Lu, Minxia
    PSYCHOLOGY HEALTH & MEDICINE, 2023, 28 (03) : 799 - 811
  • [40] Serum Resistin Levels and Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
    Momiyama, Yukihiko
    Ohmori, Reiko
    Uto-Kondo, Harumi
    Tanaka, Nobukiyo
    Kato, Ryuichi
    Taniguchi, Hiroaki
    Arakawa, Koh
    Nakamura, Haruo
    Ohsuzu, Fumitaka
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2011, 18 (02) : 108 - 114